Oligodendroglioma other imaging findings: Difference between revisions

Jump to navigation Jump to search
Sujit Routray (talk | contribs)
Sujit Routray (talk | contribs)
Line 11: Line 11:
* [[N-acetyl aspartate]] (NAA) peak is dominant
* [[N-acetyl aspartate]] (NAA) peak is dominant
*[[Choline]]-to-[[creatine]] ratio of less than 3:1
*[[Choline]]-to-[[creatine]] ratio of less than 3:1
*Reduction of [[N-acetyl aspartate]|NAA]]/[[creatine]] ratio
*Reduction of [[N-acetyl aspartate|NAA]]/[[creatine]] ratio


==References==
==References==

Revision as of 18:08, 12 October 2015

Oligodendroglioma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Oligodendroglioma from other Diseases

Epidemiology & Demographics

Risk Factors

Screening

Natural History, Complications, and Prognosis

Diagnosis

Staging

History & Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Oligodendroglioma other imaging findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Oligodendroglioma other imaging findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Oligodendroglioma other imaging findings

CDC on Oligodendroglioma other imaging findings

Oligodendroglioma other imaging findings in the news

Blogs on Oligodendroglioma other imaging findings

Directions to Hospitals Treating Oligodendroglioma

Risk calculators and risk factors for Oligodendroglioma other imaging findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]

Overview

Other Imaging Findings

Other imaging studies for oligodendroglioma include:[1]

Magnetic Resonance Spectroscopy

References

  1. Eskandar EN, Loeffler JS, O'Neill AM, Hunter GJ, Louis DN (2004). "Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 33-2004. A 34-year-old man with a seizure and a frontal-lobe brain lesion". N Engl J Med. 351 (18): 1875–82. doi:10.1056/NEJMcpc049025. PMID 15509821.


Template:WikiDoc Sources